Achieving Better Outcomes through Deprescribing in Hospice

Achieving Better Outcomes through Deprescribing in Hospice 

Polypharmacy is an issue for all patients over the age of 65 that escalates during end of life when patients are prescribed both maintenance medications for chronic disease states and symptom management medications. Upon admission to hospice, our pharmacy call center profiles at least 20 medications for each patient of which one-third are of questionable benefit to a patient at end of life. CMS continues to struggle with the high percentage of medications still being billed through Medicare Part D for patients on the hospice benefit. Discontinuing non-beneficial medications at end of life has proven to improve patient comfort and quality of life via data published in recent literature. Hospice clinicians can make an impact by framing medication discontinuation discussions therapeutically, clarifying that stopping or adjusting meds is done to prevent harm and promote patient well-being and time them on hospice admission, during changes in level of care and/or when a trust relationship is formed to ease transition.

$0.00

Hours: 1.25
PSCC-ABO-ENCLARA

Certificates

Certificates provided by accrediting body (0 Match)

Course Details

Course Code: PSCC-ABO-ENCLARA
Hours: 1.25
Type: Online Course
Content Expiration Date: 12/31/2020
Learning Objectives:
Recognize barriers to deprescribing
Identify common classes of medications appropriate for discontinuation in hospice
Describe communication tactics for discussing medication discontinuation with patients and family members

Outline:
`

Instructor: Terri Maxwell, PhD, APRN
Terri Maxwell, PhD, APRN, is Chief Clinical Officer of Turn-Key Health, a division of Enclara Pharmacia. A frequent presenter at state and national meetings, Terri is a well-published author on a range of palliative care topics.  She obtained her BSN from the University of Rhode Island and a Masters Degree and PhD in Nursing from the University of Pennsylvania. Disclosure: Terri Maxwell, PhD, APRN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: Nurses; in the following settings: Hospice, Palliative Care.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.